Biomanufacturing Viral Detection and Quantification Market
完整報告名稱與涵蓋範圍
Biomanufacturing Viral Detection and Quantification Market Size, Share & Trends Analysis Report By Offering Type (Consumables, Instruments, Services), By Technology (PCR, ELISA, Flow Cytometry, Plaque Assay, and Others), Application, End User, Region, And Segment Forecasts, 2023-2031
報告摘要
A CAGR of 8.8% is forecasted for the global Biomanufacturing Viral Detection and Quantification Market over the assessment period of 2023 through 2031.
Biomanufacturing Viral Detection and Quantification encompasses challenges.
Several factors contribute to this trajectory, including heightened interest in next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biomanufacturing Viral Detection and Quantification Market Snapshot
Chapter 4. Global Biomanufacturing Viral Detection and Quantification Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Offering Type Estimates & Trend Analysis
5.1. By Offering Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Offering Type :
5.2.1. Consumables
5.2.2. Instruments
5.2.2.1. Kits and Assays
5.2.2.2. Accessories
5.2.3. Services
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. By Offering Type & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Technology:
6.2.1. PCR
6.2.2. ELISA
6.2.3. Flow Cytometry
6.2.4. Plaque Assay
6.2.5. Others
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Offering Type & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Application:
7.2.1. Blood and Blood Products Manufacturing
7.2.2. Vaccines and Therapeutics Manufacturing
7.2.3. Cellular and Gene Therapy Products Manufacturing
7.2.4. Stem Cell Products Manufacturing
7.2.5. Tissue and Tissue Products Manufacturing
Chapter 8. Market Segmentation 4: By End user Estimates & Trend Analysis
8.1. By Offering Type & Market Share, 2019-2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End user:
8.2.1. Life Science Companies
8.2.2. Testing Laboratories
8.2.3. CROs and CDMOs
Chapter 9. Biomanufacturing Viral Detection and Quantification Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Offering Type, 2023-2031
9.1.2. North America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
9.1.3. North America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
9.1.4. North America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By, End User 2023-2031
9.1.5. North America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) By Offering Type, 2023-2031
9.2.2. Europe Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
9.2.3. Europe Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Application 2023-2031
9.2.4. Europe Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By End user,2023-2031
9.2.5. Europe Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by country, 2023-2031
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by By Offering Type, 2023-2031
9.3.2. Asia Pacific Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
9.3.3. Asia Pacific Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
9.3.4. Asia Pacific Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By End user, 2023-20
9.3.5. Asia Pacific Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by country, 2023-2031
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by By Offering Type, 2023-2031
9.4.2. Latin America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
9.4.3. Latin America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
9.4.4. Latin America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By End user, 2023-2031
9.4.5. Latin America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by country, (US$ Million) 2023-2031
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by By Offering Type, (US$ Million)
9.5.2. Middle East & Africa Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
9.5.3. Middle East & Africa Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
9.5.4. Middle East & Africa Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By End user, 2023-2031
9.5.5. Middle East & Africa Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by country, (US$ Million) 2023-2031
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Danaher Corporation
10.2.2. Merck KGaA
10.2.3. TAKARA HOLDINGS INC.
10.2.4. Thermo Fisher Scientific Inc.
10.2.5. Agilent Technologies, Inc.
10.2.6. Sartorius AG
10.2.7. Charles River Laboratories
10.2.8. Bio-Rad Laboratories, Inc.
10.2.9. PerkinElmer, Inc.
10.2.10. Promega Corporation
10.2.11. QIAGEN N.V.
10.2.12. Genscript Biotech Corporation
10.2.13. Norgen Biotek Corp.
10.2.14. New England Biolabs
10.2.15. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們